150 related articles for article (PubMed ID: 18550466)
21. The evaluation of the sentinel lymph nodes status in breast carcinoma using microscopic, immunohistochemical and cytomorphometric methods in order to establish new stadializations and therapeutic schemes.
Stolnicu S; Coros MF; Podeanu DM; Carata E; Mezei T; Muscă S; Podoleanu C; Rădulescu D
Rom J Morphol Embryol; 2009; 50(1):51-60. PubMed ID: 19221645
[TBL] [Abstract][Full Text] [Related]
22. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
[TBL] [Abstract][Full Text] [Related]
23. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.
Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M
Breast J; 2008; 14(6):551-5. PubMed ID: 19000054
[TBL] [Abstract][Full Text] [Related]
24. Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer.
Takei H; Kurosumi M; Yoshida T; Ninomiya J; Ishikawa Y; Hayashi Y; Tozuka K; Asakawa H; Oba H; Inoue K; Tabei T
Breast; 2009 Aug; 18(4):244-7. PubMed ID: 19559610
[TBL] [Abstract][Full Text] [Related]
25. Alternaria simulating metastatic breast carcinoma in cytokeratin-stained axillary sentinel node sections.
Robinson BD; Amin BD; Hoda SA
Breast J; 2008; 14(1):120-1. PubMed ID: 18186881
[No Abstract] [Full Text] [Related]
26. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
27. Surgical management of the axilla: do intramammary nodes matter?
Pugliese MS; Stempel MM; Cody HS; Morrow M; Gemignani ML
Am J Surg; 2009 Oct; 198(4):532-7. PubMed ID: 19800463
[TBL] [Abstract][Full Text] [Related]
28. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
29. Epithelial inclusion in axillary lymph node associated with a breast carcinoma: report of a case with a review of the literature.
Fraggetta F; Vasquez E
Pathol Res Pract; 1999; 195(4):263-6. PubMed ID: 10337666
[TBL] [Abstract][Full Text] [Related]
30. Breast epithelial cells in dermal angiolymphatic spaces: a manifestation of benign mechanical transport.
Diaz NM; Mayes JR; Vrcel V
Hum Pathol; 2005 Mar; 36(3):310-3. PubMed ID: 15791577
[TBL] [Abstract][Full Text] [Related]
31. Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast.
Cheung KJ; Tam W; Chuang E; Osborne MP
Breast J; 2007; 13(4):413-7. PubMed ID: 17593048
[TBL] [Abstract][Full Text] [Related]
32. Intra-operative imprint cytology for assessing the sentinel node in breast cancer: results of its routine use over 8 years.
Contractor K; Gohel M; Al-Salami E; Kaur K; Aqel N; Nigar E; Burke M; Singhal H
Eur J Surg Oncol; 2009 Jan; 35(1):16-20. PubMed ID: 18554859
[TBL] [Abstract][Full Text] [Related]
33. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
34. Intraoperative cytologic evaluation of sentinel lymph nodes in patients with breast carcinoma by scrape preparation.
Feng J; Bernacki EG
Diagn Cytopathol; 2008 Nov; 36(11):790-3. PubMed ID: 18831017
[TBL] [Abstract][Full Text] [Related]
35. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancer.
Lang JE; Liu LC; Lu Y; Jenkins T; Hwang SE; Esserman LJ; Ewing CA; Alvarado M; Morita E; Treseler P; Leong SP
Breast J; 2009; 15(3):242-6. PubMed ID: 19645778
[TBL] [Abstract][Full Text] [Related]
37. Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes.
Karam AK; Hsu M; Patil S; Stempel M; Traina TA; Ho AY; Cody HS; Port ER; Morrow M; Gemignani ML
Ann Surg Oncol; 2009 Jul; 16(7):1952-8. PubMed ID: 19381724
[TBL] [Abstract][Full Text] [Related]
38. Inclusions of benign nevus cells in the capsule of axillary lymph nodes in three cases of breast cancer.
Gădăleanu V; Mureşan R
Morphol Embryol (Bucur); 1984; 30(2):137-9. PubMed ID: 6330543
[TBL] [Abstract][Full Text] [Related]
39. Pathological axillary lymph node status in HER-2 receptor positive and negative breast cancers.
Chen JH; Agrawal G; Carpenter P; Mehta RS; Nalcioglu O; Su MY
Ann Surg Oncol; 2008 Mar; 15(3):941-2. PubMed ID: 18004624
[No Abstract] [Full Text] [Related]
40. Benign epithelial inclusions in axillary lymph nodes: report of 18 cases and review of the literature.
Fellegara G; Carcangiu ML; Rosai J
Am J Surg Pathol; 2011 Aug; 35(8):1123-33. PubMed ID: 21753696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
